Literature DB >> 11721197

[Recurrent inguinal hernia after mesh hernioplasty. An emerging problem?].

A Garavello1, S Manfroni, G F Teneriello, A Mero, D Antonellis.   

Abstract

BACKGROUND: In spite of the successful results of tension free hernioplasties, recurrent inguinal hernias are not an uncommon finding in the clinical practice.
METHODS: The authors report their experience in 24 patients observed from January 1994 to December 2000 (23 men, 1 women, min. age 28 yrs, max 78 yrs, mean 58 yrs) who had recurrent inguinal hernia after a tension free hernioplasty. In 22 patients a tension free hernioplasty (Lichtenstein technique 5 patients, Trabucco 7 patients, unclassifiable 10 patients) through an anterior approach was performed while in two, respectively, a Stoppa procedure and a laparoscopic hernioplasty were the first operations; mean recurrence time was 17 months.
RESULTS: Mesh and/or plug dislocation was the most frequent cause of recurrence (15 patients), followed by a failure of the internal ring reconstruction (6 patients) and loss of the pubic stitch (2 patients); in 1 patient the mesh was of reabsorbable type.
CONCLUSIONS: Mesh hernioplasties represent a valuable progress in inguinal hernia therapy, but increasing clinical experience shows that, together with the experience of the surgeon in the surgical technique, suture of a wide mesh to the surrounding tissues and a adequate inguinal ring reconstruction are critical condition for good results.

Entities:  

Mesh:

Year:  2001        PMID: 11721197

Source DB:  PubMed          Journal:  Minerva Chir        ISSN: 0026-4733            Impact factor:   1.000


  2 in total

1.  Recurrent inguinal hernia due to mesh dissolution: two case reports.

Authors:  M Shamim
Journal:  Hernia       Date:  2009-07-28       Impact factor: 4.739

2.  [Management of recurrent inguinal hernia after previous mesh repair: a challenge].

Authors:  R Schwab; J Conze; A Willms; U Klinge; H-P Becker; V Schumpelick
Journal:  Chirurg       Date:  2006-06       Impact factor: 0.955

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.